Logos Global Management »

Palatin Technologies shares owned by Logos Global Management

Quarter-by-quarter ownership of Palatin Technologies (PTN) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Palatin Technologies

Tip: Access up to 7 years of quarterly data

All positions including Palatin Technologies held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palatin Technologies by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 140k 15.38

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences (IDYA)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Erasca (ERAS)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Tango Therapeutics (TNGX)
Avidity Biosciences Ord (RNA)
Biogen Idec (BIIB)
Immunovant (IMVT)

View all positions for Logos Global Management

Top funds holding Palatin Technologies

Logos Global Management
Point72 Asset Management
Superstring Capital Management
Vanguard Group
Geode Capital Management
Jane Street
Bleichroeder
UBS Group
Us Bancorp
BlackRock
Atlantic Trust
Advisor Group Holdings
Wells Fargo & Company
MAI Wealth Advisors

View all funds holding Palatin Technologies